Science Explorer Back to mapMap
Discussion
Company · Beverly · United States

Adeptrix (United States)

adeptrix.comROR OpenAlex
Research works
3
▲ 7% vs 2018-21
Citations
14
4.1 per fractional work
Top-10% rate
4.4%
all institutions 10.0%
Open access
61%
world 40%
International
21%
world 18%
Adeptrix (United States)

Not ranked overall: Adeptrix (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Adeptrix (United States) work in?

In all years, 39% of research at Adeptrix (United States) is in Life Sciences, 39% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (39%), Medicine (39%), Chemistry (15%).

Life Sciences: 1 fractional works · 39.4% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 39.4% of its workHealth Sciences: 1 fractional works · 39.4% of its workMedicine: 1 fractional works · 39.4% of its workPhysical Sciences: 1 fractional works · 21.2% of its workChemistry: 0 fractional works · 15.2% of its workEngineering: 0 fractional works · 6.1% of its workALL ITS WORKAdeptrix (UnitedStates)3fractional works, all years
Life Sciences39%Physical Sciences21%Health Sciences39%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology139.4%
    1. Medicine139.4%
    1. Chemistry015.2%
    2. Engineering06.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Adeptrix (United States)?

The most cited paper from Adeptrix (United States) is "Integrated -omics approach reveals persistent DNA damage rewires lipid metabolism and histone hyperacetylation via MYS-1/Tip60" (Shruthi Hamsanathan, Tamil S. Anthonymuthu, Suhao Han et al., 2022), with 31 citations. Next come "Formation of protein adducts with Hydroperoxy-PE electrophilic cleavage products during ferroptosis" (29) and "Mitochondrial bioenergetics and cardiolipin remodeling abnormalities in mitochondrial trifunctional protein deficiency" (17).

Most cited papers
#PaperReleasedCitations
1 Integrated -omics approach reveals persistent DNA damage rewires lipid metabolism and histone hyperacetylation via MYS-1/Tip60 Shruthi Hamsanathan, Tamil S. Anthonymuthu, Suhao Han et al. · Science Advances Open access 16 Feb 2022 31
2 Formation of protein adducts with Hydroperoxy-PE electrophilic cleavage products during ferroptosis Andrew A. Amoscato, Tamil S. Anthonymuthu, Alexandr A. Kapralov et al. · Redox Biology Open access 22 May 2023 29
3 Mitochondrial bioenergetics and cardiolipin remodeling abnormalities in mitochondrial trifunctional protein deficiency Eduardo Vieira Neto, Meicheng Wang, Austin J. Szuminsky et al. · JCI Insight Open access Aug 2024 17
4 Affinity-Bead Assisted Mass Spectrometry (Affi-BAMS): A Multiplexed Microarray Platform for Targeted Proteomics Ghaith M. Hamza, Vladislav B. Bergo, Sergey V. Mamaev et al. · International Journal of Molecular Sciences Open access 16 Mar 2020 13
5 Affi-BAMS™: A Robust Targeted Proteomics Microarray Platform to Measure Histone Post-Translational Modifications Ghaith M. Hamza, Eric Miele, Don M. Wojchowski et al. · International Journal of Molecular Sciences Open access 13 Jun 2023 1
All 8 most cited papers, with filters and sorting

Which research topics does Adeptrix (United States) publish most on?

By volume in 2022-now: Biotin and Related Studies, Cholinesterase and Neurodegenerative Diseases, Alzheimer's disease research and treatments and Peptidase Inhibition and Analysis.

Biotin and Related Studies0Biotin and Related Studies: 0 fractional worksCholinesterase and Neuro…0Cholinesterase and Neurodegenerative Diseases: 0 fractional worksAlzheimer's disease rese…0Alzheimer's disease research and treatments: 0 fractional worksPeptidase Inhibition and Analysis: 0 fractional worksMitochondrial Function and Pathology: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional worksUbiquitin and proteasome pathways: 0 fractional works
Cell BiologyPharmacologyPhysiologyOncology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Biotin and Related Studies Cell Biology 0 works
  2. 2 Cholinesterase and Neurodegenerative Diseases Pharmacology 0 works
  3. 3 Alzheimer's disease research and treatments Physiology 0 works
  4. 4 Peptidase Inhibition and Analysis Oncology 0 works
  5. 5 Mitochondrial Function and Pathology Molecular Biology 0 works
  6. 6 Protein Degradation and Inhibitors Molecular Biology 0 works
  7. 7 Ubiquitin and proteasome pathways Molecular Biology 0 works
  8. 8 Metabolism and Genetic Disorders Clinical Biochemistry 0 works
  9. 9 ATP Synthase and ATPases Research Molecular Biology 0 works
  10. 10 Trace Elements in Health Nutrition and Dietetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available60.6%not open39.4%

World: 40% of research is openly available.

with international co-authors20.7%domestic only79.3%

World: 18% is written across borders.

How has Adeptrix (United States)'s research output changed?

Output in 2022-2025 was 7% higher than in 2018-2021.

20152020

Other research institutions in Beverly

All research institutions in Beverly

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Adeptrix (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.